CCHT(SZ:000661) Xin Lang Cai Jing·2025-10-29 02:28Core Viewpoint - Changchun High-tech's stock price has shown volatility, with a year-to-date increase of 17.78% but a recent decline over the past five and twenty trading days, indicating potential market concerns or profit-taking behavior [1] Group 1: Company Overview - Changchun High-tech Industry (Group) Co., Ltd. was established on June 10, 1993, and listed on December 18, 1996, with its main business involving the research, production, and sales of biopharmaceuticals and traditional Chinese medicine, alongside real estate development and property management [2] - The company's revenue composition is primarily from the pharmaceutical sector (92.83%), followed by real estate (6.81%) and services (0.36%) [2] - As of June 30, the number of shareholders was 109,100, a decrease of 12.78% from the previous period, with an average of 3,662 circulating shares per shareholder, an increase of 14.66% [2] Group 2: Financial Performance - For the first half of 2025, Changchun High-tech reported operating revenue of 6.603 billion yuan, a year-on-year decrease of 0.54%, and a net profit attributable to shareholders of 983 million yuan, down 42.85% year-on-year [2] - The company has distributed a total of 4.791 billion yuan in dividends since its A-share listing, with 3.259 billion yuan distributed over the past three years [3] Group 3: Shareholder Structure - As of June 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the third-largest shareholder, holding 8.4381 million shares, a decrease of 3.4502 million shares from the previous period [3] - Other notable shareholders include Huatai-PB CSI 300 ETF and E Fund CSI 300 Medicine ETF, with varying changes in their holdings [3]